RxDoctor Payments Data

Steven Richey, MD

Interventional Pain Medicine · Southaven, MSNPI 1417953050

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Pharmacosmos Therapeutics Inc. at 35.6% of the total. Reporting peaked in 2024 at $628 and has fallen 69.4% since, to $192 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MS, where the typical reported total is $2,720.

$2,092in general payments, 2019–2025

Across 54 payments — averaging $38.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacosmos Therapeutics Inc.$744
  • Boston Scientific$539
  • Abbott$179
  • US Oncology Corporate, Inc.$118
  • Onmark, Inc.$86
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$73
  • plus $353 from 13 others

What the payments were for

  • Food & beverage$1,91391%
  • Education$1799%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,092 in reported general payments places this provider in the 45th percentile of 24 interventional pain medicine providers in Mississippi.

See all interventional pain medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$68,200
Medicare patients
220
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$16,487
Levothyroxine Sodium85$620
Isosorbide Dinitrate20$571
ClopidogrelClopidogrel Bisulfate36$324
Amlodipine Besylate70$280
Ropinirole Hcl39$222
Oxybutynin Chloride14$218
Donepezil Hcl50$213
Gabapentin36$206
Quetiapine Fumarate40$191
Potassium Chloride17$187
Carvedilol45$184
Lisinopril24$164
Duloxetine Hcl14$156
Memantine Hcl17$152

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Southaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →